Skip to main content

AstraZeneca says DOJ closes probe into drug trial

By WTOP Staff

WASHINGTON (AP) — British drugmaker AstraZeneca says the U.S. Department of Justice has closed its investigation into a clinical trial of the company’s blood thinner Brilinta, and plans no further action.

The company announced in October 2013 that federal officials were looking into the 18,000-patient study, which began in 2009.

The study, dubbed PLATO, showed that patients taking Brilinta instead of competing drug Plavix were less likely to experience various heart-related problems, including heart attack, stroke and death. News of the U.S. investigation has raised questions about the validity of the trial and the benefits of the drug, which hit the market in 2011.

The London-based drugmaker said in a statement Tuesday: “AstraZeneca has always had absolute confidence in the integrity of the PLATO trial.”

Brilinta had sales of $283 million last year.

Copyright 2014 The Associated Press. All rights reserved. This material may not be published, broadcast, rewritten or redistributed.

Emergency guide: What you should do to prepare for emergencies

By WTOP Staff
WASHINGTON — Do you know what you'd do if an emergency hits? What if you're at work, your spouse is stuck in traffic and your children are in school? There's no way to plan for every emergency, but you can make sure you're prepared for different scenarios, including making a plan for your family and building a kit of emergency supplies.
Read Next Story

Related News

Cards, gifts cross religious lines

Mind your mouth: How oral health affects overall health

5 questions to ask before buying a winter home